BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19620208)

  • 1. Lateral medullary syndrome with anti-neuronal antibodies (anti-Ta/Ma2) in primary Sjogren's syndrome.
    Mehta P; Fernando MM; Pickering MC; Wilson Y; Molloy S; Colaco CB
    Rheumatology (Oxford); 2009 Sep; 48(9):1174-6. PubMed ID: 19620208
    [No Abstract]   [Full Text] [Related]  

  • 2. Sensitivity and specificity of anti-alpha-fodrin antibodies in primary Sjögren's syndrome.
    Szántó A; Csípo I; Zeher M
    J Rheumatol; 2005 Jan; 32(1):197; author reply 197-8. PubMed ID: 15630756
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-Ma2/Ta antibodies in a woman with primary lateral sclerosis-like phenotype and Sjögren syndrome.
    Piccolo G; Tavazzi E; Jarius S; Alfonsi E; Cavagna L; Piccolo L; Zardini E; Voltz R; Franciotta D
    Neurol Sci; 2011 Oct; 32(5):915-7. PubMed ID: 21369848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid anti-SSA autoantibodies in primary Sjogren's syndrome with central nervous system involvement.
    Mégevand P; Chizzolini C; Chofflon M; Roux-Lombard P; Lalive PH; Picard F
    Eur Neurol; 2007; 57(3):166-71. PubMed ID: 17213724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of anticardiolipin antibodies in patients with primary Sjögren's syndrome.
    Müller K; Oxholm P; Madsen MH; Wiik A
    Autoimmunity; 1988; 2(1):92-3. PubMed ID: 3155155
    [No Abstract]   [Full Text] [Related]  

  • 6. [Subacute neuropathy, multiple cancers, and Gougerot-Sjögren syndrome: contribution of anti-Hu antibody].
    Auf G; Benyahia B; Orcel B; Beigelman C; Delattre JY
    Rev Neurol (Paris); 2001 Feb; 157(2):219-21. PubMed ID: 11283468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to alpha-fodrin derived peptide in Sjögren's syndrome.
    He J; Chen QL; Li ZG
    Ann Rheum Dis; 2006 Apr; 65(4):549-50. PubMed ID: 16531552
    [No Abstract]   [Full Text] [Related]  

  • 8. Nailfold capillaroscopy abnormalities are associated with the presence of anti-endothelial cell antibodies in Sjogren's syndrome.
    Riccieri V; Sciarra I; Ceccarelli F; Alessandri C; Croia C; Vasile M; Modesti MG; Priori R; Valesini G
    Rheumatology (Oxford); 2009 Jun; 48(6):704-6. PubMed ID: 19307256
    [No Abstract]   [Full Text] [Related]  

  • 9. Antifodrin antibodies in Sjogren's syndrome: a review.
    Witte T
    Ann N Y Acad Sci; 2005 Jun; 1051():235-9. PubMed ID: 16126964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Paraneoplastic neurological syndrome associated with anti-Ma2 antibodies].
    Khammassi N; Balhouane I; Gargouri A; Gouider R; Cherif O
    Rev Neurol (Paris); 2012 Feb; 168(2):192-3. PubMed ID: 21962240
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-cyclic citrullinated peptide antibodies in patients with primary Sjögren's syndrome.
    Tobón GJ; Correa PA; Anaya JM
    Ann Rheum Dis; 2005 May; 64(5):791-2. PubMed ID: 15834066
    [No Abstract]   [Full Text] [Related]  

  • 12. Do male patients with primary Sjögren's syndrome have a higher frequency of autoantibodies?
    Ramos-Casals M; Cervera R; Font J
    J Rheumatol; 2005 Aug; 32(8):1634-5; author reply 1635-6. PubMed ID: 16078351
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of severe inflammatory polyarthritis in primary Sjögren's syndrome: clinical, serologic, and HLA analysis.
    Mohammed K; Pope J; Le Riche N; Brintnell W; Cairns E; Coles R; Bell DA
    J Rheumatol; 2009 Sep; 36(9):1937-42. PubMed ID: 19487261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic acetylcholine receptor autoantibodies in patients with Sjögren's syndrome.
    Naito Y; Matsumoto I; Wakamatsu E; Goto D; Sugiyama T; Matsumura R; Ito S; Tsutsumi A; Sumida T
    Ann Rheum Dis; 2005 Mar; 64(3):510-1. PubMed ID: 15708912
    [No Abstract]   [Full Text] [Related]  

  • 15. An unusually complicated case of primary Sjögren's syndrome: development of transient "lupus-type" autoantibodies following silicone implant rejection.
    Asherson RA; Shoenfeld Y; Jacobs P; Bosman C
    J Rheumatol; 2004 Jan; 31(1):196-7. PubMed ID: 14705243
    [No Abstract]   [Full Text] [Related]  

  • 16. Paraneoplastic antineuronal antibodies in patients with systemic autoimmune diseases.
    Benyahia B; Amoura Z; Rousseau A; Le Clanche C; Carpentier A; Piette JC; Delattre JY
    J Neurooncol; 2003 May; 62(3):349-51. PubMed ID: 12777089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sensory ataxic neuropathy presenting anti-a-fodrin antibody associated with rheumatoid arthritis].
    Sakazume Y; Shizuka M; Tanaka M; Okamoto K; Hayashi Y
    Rinsho Shinkeigaku; 1999 Sep; 39(9):935-9. PubMed ID: 10614157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies.
    Iwamoto N; Kawakami A; Tamai M; Fujikawa K; Arima K; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Eguchi K
    J Rheumatol; 2009 Jan; 36(1):113-5. PubMed ID: 19132785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of epitopes recognized by anti-alpha-fodrin autoantibodies in children with Sjogren's syndrome].
    Shiari R
    Hokkaido Igaku Zasshi; 2005 Sep; 80(5):441-7. PubMed ID: 16238239
    [No Abstract]   [Full Text] [Related]  

  • 20. Antidisialosyl antibodies in chronic idiopathic ataxic neuropathy.
    Serrano-Munuera C; Rojas-García R; Gallardo E; De Luna N; Buenaventura I; Ferrero M; García T; García-Merino JA; González-Rodríguez C; Guerriero A; Marco M; Márquez C; Grau JM; Graus F; Illa I
    J Neurol; 2002 Nov; 249(11):1525-8. PubMed ID: 12420092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.